Merck
CN
高级检索
Chemical Structure Search
Search Within
文件类型

202-803-3

应用筛选条件
关键词:'202-803-3'
显示 1-24 共 24 条结果 关于 "202-803-3" 范围 技术文档
Data Sheet - T6819
pSer199/202) (T6819) - Data Sheet Anti-phospho-TAU (pSer199/202) produced in rabbit, affinity isolated antibody Catalog Number T6819 Product Description Anti-phospho-Tau (pSer199/202) is produced
Data Sheet - T8069
and threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites are
Data Sheet - T6944
and threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites
Data Sheet - T8319
and threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites
Data Sheet - T7069
and threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites
Data Sheet - T7319
and threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3 transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites
Data Sheet - T7819
threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites are
Data Sheet - T7444
and threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites
Data Sheet - T7694
and threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites
Data Sheet - T6694
threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites are
Data Sheet - T8194
and threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites
Data Sheet - T7944
and threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites
Data Sheet - T7569
and threonine residues. Specifically, TPKII phosphorylates serines 202 and 404. GSK-3β transfection phosphorylates serines 199, 202, 235, 396, 404 and 413, and threonines 205 and 231. These sites
Data Sheet - L0415
S., and Sternglanz, R., Trends Genet., 10, 286-292 (1994). 7. Gyuris, J., et al., Cell, 75, 791-803 (1993). 8. Ruden, D.M., et al., Nature, 350, 250-252 (1991). 9. Yang, X., et al., Cell, 89, 1067-1076
Product Information Sheet - B9808
729-736 (1985). 3. Sutton, M.D., et al., Annu. Rev. Genet., 34, 479-497 (2000). 4. Little, J.W., and Mount, D.W., Cell, 29, 11-22 (1982). 5. Gyuris, J., et al., Cell, 75, 791-803 (1993). 6. Fields
Poster: Purification of Peptides from Serum and Cell Lysates for Mass Spectrometry, ASMS, 2004
, G.B., Simone, C., Fishman, D.A., Kohn, E.C., Liotta, L.A. Lancet (202) 359, 572. 5. Bischoff, R., Luider, R.M. J.Chrom.B, (2004) 803, 27-40. 6. Stevens, E.V., Liotta, L.A., Kohn, E.C., J. Gynecol. Cancer
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
Pract. Res. Clin. Endocrinol. Metab., 13, 583-595 (1999). 121. Jessop, D.S., et al., Peptides, 22, 803-807 (2001). 122. Uzuki, M., et al., Clin. Sci. (Lond), 100, 577-589 (2001). 123. Chan, E. C., et al
Research Focus - Volume 2, 2013
truncated at Asp421) Hu ELISA, IHC, WB 100 µg MAB5430 Anti-Tau (3-repeat isoform RD3) Antibody, clone 8E6/C11 Hu IHC, WB 200 µL 05-803 Anti-Tau (4-repeat isoform RD4) Antibody, clone 1E1/A6 Bov, Hu
Tools and Tips for Analyzing Apoptosis: A Kit Selection Guide
282 .4 5 mg €58 AG 82 658400 202 .2 5 mg €63 AG 490 658401 294 .3 5 mg €49 Anandamide 172100 347 .5 5 mg €105 Anisomycin, Streptomyces griseolus 176880 265 .3 10 mg
XP725 Worksheet for Lot Number 071M4826
1417 8 2 4 1 Tau pSer199 202 T6819 1418 8 2 4 2 Tau pSer199 202 T6819 1419 8 2 4 3 Tau T5530 1420 8 2 4 4 Tau T5530 Tenascin T25511421 8 2 4 5 1422
Antibody SourceBook, Sixth Edition, DIST version
Modified, Mycobacterium butyricum 3��289 1 Set €126 Freund’s Incomplete Adjuvant, Modified 3��291 10 ml €32 Hemocyanin, Concholepas concholepas, Glycerol 37�803 1 g €�22 Hemocyanin, Keyhole Limpet
Halal Certificate
LAURYL ACETATE W261602 C47742 HC-23SI3285 802. LAURYL ALCOHOL 98%, FG W261718 A65835 HC-23SIFD87 803. LAVENDER OIL, 40/42% FLEURS W262218 C54815 HC-23SIX705 804. LAVENDER OIL, CERTIFIED ORGANIC (NOP
Halal Certificate
LAURYL ACETATE W261602 C47742 HC-22SIB507 802. LAURYL ALCOHOL 98%, FG W261718 A65835 HC-22SI5O09 803. LAVENDER OIL, 40/42% FLEURS W262218 C54815 HC-22SI9N26 804. LAVENDER OIL, CERTIFIED ORGANIC (NOP
Inhibitor Sourcebook 3rd Edition
IC50 = 12 µM). 25 mg Lovastatin 438185 (Mevinolin; Mk-803) An anti-hypercholesterolemic agent that inhibits the activity of 3-hydroxy-3- methylglutaryl coenzyme A (HMG-CoA) reductase. Has been shown